| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Ipsen |
| Recipient: You |
| Company: Array BioPharma |
| Recipient: You |
| Company: AstraZeneca/MedImmune |
| Recipient: You |
| Company: Cancer Commons |
| Recipient: You |
| Company: Legend Biotech |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Celgene |
| Recipient: Your Institution |
| Company: Bristol-Myers Squibb |
| Recipient: Your Institution |
| Company: AstraZeneca/MedImmune |
| Recipient: Your Institution |
| Company: Merck Serono |
| Recipient: Your Institution |
| Company: Agios |
| Recipient: Your Institution |
| Company: Five Prime Therapeutics |
| Recipient: Your Institution |
| Company: MedImmune |
| Recipient: Your Institution |
| Company: ArQule |
| Recipient: Your Institution |
| Company: Genentech |
| Recipient: Your Institution |
| Company: Sillajen |
| Recipient: Your Institution |
| Company: CASI Pharmaceuticals |
| Recipient: Your Institution |
| Company: Immunesensor |
| Recipient: Your Institution |
| Company: Tolero Pharmaceuticals |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| not answered |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|